Airfinity Ltd is a science information and analytics company specializing in predictive health intelligence. They provide data-driven insights and forecasts on disease outbreaks, pharmaceutical pipelines, and market dynamics within the life sciences and healthcare sectors. Their platform is utilized by governments, financial institutions, pharmaceutical companies, and research organizations worldwide to inform strategic decision-making, risk assessment, and resource allocation in response to global health challenges and opportunities. By leveraging advanced data analytics, machine learning, and expert analysis, Airfinity aims to deliver timely and actionable intelligence to navigate the complexities of the evolving healthcare landscape.
The London headquarters serves as the central operational base, housing key functions including research and development, data science, commercial operations, product development, and corporate leadership.
Situated in a modern office building, the headquarters likely features collaborative workspaces and advanced technological infrastructure to support its data-intensive operations. The specific building, 'The Kodak,' suggests a redeveloped or modern commercial space.
The work culture at Airfinity's HQ is likely dynamic, innovative, and mission-driven, characterized by a strong emphasis on data accuracy, analytical rigor, and collaboration among experts from diverse fields like epidemiology, data science, and market analysis.
Its London location provides Airfinity with access to a rich talent pool, proximity to major pharmaceutical companies, regulatory bodies, financial institutions, and global health organizations, facilitating partnerships and client engagement.
Airfinity supports a global client base from its main offices in London and New York. Its intelligence platform and analytical services cover worldwide health events, pharmaceutical developments, and life science market trends, making its insights relevant to organizations operating across numerous countries and continents. Their data collection and analysis are inherently global, tracking diseases, clinical trials, and market access information from around the world.
First Floor, The Kodak, 65-71 Old Pye Street
London
England
United Kingdom
Address: Specific street address not publicly listed, operating within New York City.
To strengthen Airfinity's presence in the significant North American market, providing localized support and insights to clients, and tapping into the region's rich ecosystem of life science innovation and investment.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Airfinity Ltd' leadership includes:
Airfinity Ltd has been backed by several prominent investors over the years, including:
No major C-suite executive hires or exits have been widely publicized for Airfinity Ltd in the past 12 months, suggesting stability in the top leadership team. Any senior management changes below the C-suite level may not have been publicly announced.
Discover the tools Airfinity Ltd uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Airfinity Ltd primarily utilizes the 'first.last@airfinity.com' email format for its employees. This is a common structure for professional communication within the company.
first.last@airfinity.com
Format
jane.doe@airfinity.com
Example
90%
Success rate
Airfinity News & Insights • February 7, 2024
Airfinity published an analysis on the future of mRNA technology, exploring its potential applications beyond COVID-19 vaccines. The report examines the pipeline for mRNA-based therapies and vaccines for other infectious diseases and oncology, forecasting market growth and identifying key players and challenges in the field....more
Airfinity News & Insights • January 23, 2024
Airfinity released its comprehensive outlook for the global pharmaceutical market in 2024. The report detailed expected growth drivers, including the GLP-1 drug class for obesity and diabetes, advancements in cell and gene therapies, and the impact of biosimilars. It also discussed potential challenges such as drug pricing pressures and geopolitical factors....more
Endpoints News • October 11, 2023
Endpoints News reported on an Airfinity forecast suggesting that Moderna's COVID-19 vaccine could overtake Pfizer's Comirnaty in market share by 2027. The projection was based on factors including evolving booster strategies, vaccine efficacy against new variants, and commercial execution in different global markets....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Airfinity Ltd, are just a search away.